Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up*
Read
6317
Timeswas read the article
2816
Total PDF
3501
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 28 | 11 | 39 |
| 2025 5 | 142 | 55 | 197 |
| 2025 4 | 118 | 38 | 156 |
| 2025 3 | 159 | 38 | 197 |
| 2025 2 | 117 | 62 | 179 |
| 2025 1 | 106 | 49 | 155 |
| 2024 12 | 90 | 50 | 140 |
| 2024 11 | 113 | 52 | 165 |
| 2024 10 | 143 | 67 | 210 |
| 2024 9 | 178 | 85 | 263 |
| 2024 8 | 163 | 108 | 271 |
| 2024 7 | 158 | 112 | 270 |
| 2024 6 | 132 | 80 | 212 |
| 2024 5 | 134 | 46 | 180 |
| 2024 4 | 136 | 81 | 217 |
| 2024 3 | 85 | 72 | 157 |
| 2024 2 | 109 | 74 | 183 |
| 2024 1 | 71 | 38 | 109 |
| 2023 12 | 94 | 60 | 154 |
| 2023 11 | 91 | 68 | 159 |
| 2023 10 | 60 | 70 | 130 |
| 2023 9 | 57 | 63 | 120 |
| 2023 8 | 40 | 33 | 73 |
| 2023 7 | 45 | 21 | 66 |
| 2023 6 | 41 | 33 | 74 |
| 2023 5 | 33 | 25 | 58 |
| 2023 4 | 26 | 16 | 42 |
| 2023 3 | 39 | 39 | 78 |
| 2023 2 | 28 | 29 | 57 |
| 2023 1 | 22 | 30 | 52 |
| 2022 12 | 29 | 30 | 59 |
| 2022 11 | 43 | 42 | 85 |
| 2022 10 | 34 | 36 | 70 |
| 2022 9 | 35 | 46 | 81 |
| 2022 8 | 27 | 43 | 70 |
| 2022 7 | 19 | 41 | 60 |
| 2022 6 | 31 | 56 | 87 |
| 2022 5 | 23 | 45 | 68 |
| 2022 4 | 20 | 46 | 66 |
| 2022 3 | 27 | 51 | 78 |
| 2022 2 | 17 | 29 | 46 |
| 2022 1 | 26 | 62 | 88 |
| 2021 12 | 36 | 66 | 102 |
| 2021 11 | 31 | 57 | 88 |
| 2021 10 | 42 | 65 | 107 |
| 2021 9 | 24 | 54 | 78 |
| 2021 8 | 35 | 45 | 80 |
| 2021 7 | 28 | 42 | 70 |
| 2021 6 | 23 | 38 | 61 |
| 2021 5 | 45 | 47 | 92 |
| 2021 4 | 81 | 199 | 280 |
| 2021 3 | 21 | 43 | 64 |
| 2021 2 | 22 | 13 | 35 |
| 2021 1 | 16 | 8 | 24 |
| 2020 12 | 8 | 7 | 15 |
Show all
